1. Home
  2. TECX vs FBYD Comparison

TECX vs FBYD Comparison

Compare TECX & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • FBYD
  • Stock Information
  • Founded
  • TECX 2019
  • FBYD 2021
  • Country
  • TECX United States
  • FBYD United States
  • Employees
  • TECX N/A
  • FBYD N/A
  • Industry
  • TECX
  • FBYD
  • Sector
  • TECX
  • FBYD
  • Exchange
  • TECX Nasdaq
  • FBYD Nasdaq
  • Market Cap
  • TECX 334.4M
  • FBYD 300.5M
  • IPO Year
  • TECX 2018
  • FBYD N/A
  • Fundamental
  • Price
  • TECX $21.51
  • FBYD $7.00
  • Analyst Decision
  • TECX Buy
  • FBYD
  • Analyst Count
  • TECX 6
  • FBYD 0
  • Target Price
  • TECX $79.20
  • FBYD N/A
  • AVG Volume (30 Days)
  • TECX 172.8K
  • FBYD 15.5K
  • Earning Date
  • TECX 05-08-2025
  • FBYD 05-15-2025
  • Dividend Yield
  • TECX N/A
  • FBYD N/A
  • EPS Growth
  • TECX N/A
  • FBYD N/A
  • EPS
  • TECX N/A
  • FBYD N/A
  • Revenue
  • TECX N/A
  • FBYD $6,937,000.00
  • Revenue This Year
  • TECX N/A
  • FBYD N/A
  • Revenue Next Year
  • TECX N/A
  • FBYD N/A
  • P/E Ratio
  • TECX N/A
  • FBYD $445.63
  • Revenue Growth
  • TECX N/A
  • FBYD N/A
  • 52 Week Low
  • TECX $13.70
  • FBYD $3.62
  • 52 Week High
  • TECX $61.07
  • FBYD $13.25
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.42
  • FBYD 48.44
  • Support Level
  • TECX $21.20
  • FBYD $6.28
  • Resistance Level
  • TECX $22.75
  • FBYD $7.30
  • Average True Range (ATR)
  • TECX 1.43
  • FBYD 0.57
  • MACD
  • TECX 0.01
  • FBYD -0.03
  • Stochastic Oscillator
  • TECX 41.32
  • FBYD 28.69

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FBYD Falcon's Beyond Global Inc.

Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.

Share on Social Networks: